Contact Us
Drug Search Results
More Filters [+]

UHE-105

Alternative Names: uhe-105, uhe 105, uhe105
Latest Update: 2020-07-09
Latest Update Note: Clinical Trial Update

Product Description

Therapeutics is developing UHE-105 as a treatment for scalp psoriasis. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT04243486)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Therapeutics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for UHE-105

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Psoriasis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
NCT04243486

P2

Completed

Psoriasis

2020-06-15

48%

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions